Abstract
Cigarette smoking continues to be the single, most preventable cause of death and disability in the United States. For individuals who have cancer, continuing to smoke negatively impacts their treatment, survival, and risk for second primary tumors. This review of behavioral and pharmacological approaches to smoking cessation focuses on the recent comprehensive review of cessation interventions by the Agency for Health Care Policy and Research (AHCPR), as well as on new developments in the field. An intervention model is outlined that provides oncologists with a brief and easily implemented method of systematically treating patients who smoke. By assessing patient smoking status, advising smoking patients to quit, and proactively assisting their patients in quitting, oncologists can significantly influence patient health and fulfill their professional and ethical responsibility to address this life-threatening behavior.
Similar content being viewed by others
References
USDHHS. Reducing the health consequences of smoking: 25 Years of progress-A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989
CDC. Cigarette smoking among adults-United States, 1994. Morbidity and mortality weekly report 45: 588–590, 1996
CDC. Surveillance for selected tobacco-use behaviors-United States, 1900-1994. Morbidity and mortality weekly report 43: 1–43, 1994
Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE Jr. Ihde DC, Bunn PA Jr, Matthews MJ, Makuch R: Smoking abstinence and small cell lung cancer survival. J Am Med Assoc 244: 2175–2179, 1980
Silverman S, Gorsky M, Greenspan D: Tobacco usage in patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dental Assoc 106: 33–35, 1983
Browman GP, Wong G, Hodson I et al.: Influence of ciga403 rette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328: 159–163, 1993.
Gritz ER, Kristeller J, Burns DM: High risk groups and patients with medical co-morbidity. In: Orleans CT, Slade J (eds) Nicotine Addiction: Principles and Management. Oxford University Press, New York, 1993, pp 279–309
Moore C: Cigarette smoking and cancer of the mouth, pharynx and larynx. J Am Med Assoc 218: 553–558, 1971
Stevens MH, Gardner JW, Parkin JL, Johnson LP: Head and neck cancer survival and lifestyle change. Arch Otolaryngol 109: 746–749, 1983
UDSHHS: The health benefits of smoking cessation: A report of the Surgeon General Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990
Emmons KM, Goldstein MG: Smokers who are hospitalized: A window of opportunity for cessation interventions. Preventive Medicine 21: 262–269, 1992
USDHHS. The health consequences of smoking: Nicotine Addiction-a report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Health Promotion and Education, Office on Smoking and Health, 1988
CDC. Cigarette smoking among adults-United States, 1991. Morbidity and Mortality Weekly Report 42 (12): 230-233, 1993
CDC. Health-care provider advice on tobacco use to persons aged 10-22 years-United States, 1993. Morbidity and Mortality Weekly Report 44: 826–830, 1995
Fiore MC, Bailey WC, Cohen SJ et al.: Smoking cessation. Clinical Practice Guideline No. 18. Rockville, MD: USDHHS, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0692, 1996
Fiore MC, Baker TB: Smoking cessation treatment on the good doctor club. Amer J Public Health 85: 161–163, 1995
Fiore MC, Novotny TE, Pierce JP et al.: Methods used to quit smoking in the United States. J Am Med Assoc 263: 2760–2765, 1990
Strecher VJ, Kreuter M, Boer D, Hospers KS, Skinner CS: The effects of computer-tailored smoking cessation messages in family practice settings. J Family Prac 39: 262–270, 1994
Prochaska JO, DiClementee CC, Velicer WF, Rossi JS: Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 12: 399–405, 1993
Curry SJ, McBride C, Grothaus LC, Louie D, Wagner EH: A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. J Consult Clin Psychol 63: 1005–1014, 1995
Cinciripini PM, Lapitsky LG, Seay S, Wallfish A, Kitchens K, Van Vunakis H: The effects of smoking schedules on cessation outcome: Can we improve on common methods of gradual and abrupt nicotine withdrawal. J Consult Clin Psychol 63: 388–399, 1995
Schwartz JL: Review and evaluation of smoking cessation methods: The United States and Canada, 1978-1985 (Report No. 81-2940). US Public Health Service, Besthesda, MD, 1987
Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce JP: Telephone counseling for smoking cessation-Effects of single-session and multiple-session interventions. J Consult Clinic Psychol 64 (1): 202–211, 1996
Brandon TH, Copeland AL, Saper ZL: Programmed therapeutic messages as a smoking treatment adjunct: Reducing the impact of negative affect. Health Psychol 14 (1): 41–47, 1995
Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of nicotine patch for smoking cessation. J Amer Med Assoc 271: 1940–1947, 1994
Gourlay S: The pros and cons of transdermal nicotine therapy. Med Jn Australia 160: 152–159, 1994
Po ALW: Transdermal nicotine in smoking cessation: A meta-analysis. Eur J Clin Pharmacol 45: 519–528, 1993
Silagy C, Mant D, Fowler G, Lodge M: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139–142, 1994
Tang JL, Law M, Wald N: How effective is nicotine replacement therapy in helping people to stop smoking? Brit Med J 308: 21–26, 1994
Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan I, Hays JT, Lewis SF, Baker TB: Varying nicotine patch dose and type of smoking cessation counseling. JAMA 274: 1347–1352, 1995
Dale LC, Hurt RD, Offord KP, Lawson GM: High-dose nicotine patch therapy: Percentage of replacement and smoking cessation. JAMA 274: 1353–1358, 1995
Cepeda-Benito: A meta-analytic review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 61: 822–830, 1993
Lam W, Sze PC, Sacks HS, Chalmers TC: Meta-analysis of randomized controlled trials of nicotine gum. Lancet 2: 27–30, 1987
Hajek P, Jackson P, Belcher M: Long-term use of nicotine chewing gum. JAMA 260: 2593–2596, 1988
Hughes JR, Wadland WC, Fenwick JW, Lewis J, Bickel WK: Effect of cost on the self-administration and efficacy of nicotine gum: A preliminary study. Preventive Med 20: 186–196, 1991
Benowitz NL, Jacob P 3rd, Savanapridi C: Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther 41 (4): 467–473, 1987
Fagerstrom KO, Sawe U: The pathophysiology of nicotine dependence: Treatment options and the cardiovascular safety of nicotine. Cardiovascular Risk Factors 6: 135–143, 1996
Sutherland G, Stapleton JA, Russell MAH et al.: Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 340: 324–329, 1992
Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO: Clinical pharmacokinetics of nasal nicotine delivery: A review and comparison to other nicotine systems. Clin Pharmacokinet 31: 65–80, 1996
Schneider NG, Olmtead R, Mody F, Doan K, Franzon M, Jarvik ME, Steinberg C: Efficacy of a nasal nicotine spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 90: 1671–1682, 1995
Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson FA: A doubleblind trial of a nicotine inhaler for smoking cessation. J Am Med Assoc 269: 1268–1271, 1993
Leischow SJ, Nilsson F, Franzon M, Hill A, Otte P, Merikle EP: Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behavior 20: 364–374, 1996
Schneider NG, Jarvik ME, Forsythe AB: Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 9: 149–156, 1984
Hughes JR, Higgins ST, Hatsukami DK: Effects of abstinence from tobacco: A critical review. In: Kozlowski H, Annis H, Cappell HD, Glaser F, Goodstadt M, Isreal Y, Kalant H, Sellers EM, Vingilis J (eds) Research Advances in Alcohol and Drug Problems, vol. 10. Plenum Press, New York, 1990, pp 317–398
West RJ: The 'nicotine replacement paradox' in smoking cessation: How does nicotine gum really work? Br J Addict 87: 165–167, 1992
Hughes JR: Pharmacotherapy for smoking cessation: Unvalidated assumption, anomalies, and suggestions for future research. J Consult Clin Psychol 61 (5): 751–760, 1993
Fagerstrom KO: Combined use of nicotine replacement products. Health Values 18: 15–20, 1994
Komitzer M, Bousten M, Dramaix M, Thijs J, Gustavsson G: Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Prev Med 24: 41–47, 1995
Puska P, Korhonen HJ, Vartiainen E, Urjanheimo EL, Gustavsson G, Westin A: Combined use of nicotine patch and gum compared with gum alone in smoking cessation: A clinical trial in North Karelia. Tobacco Control 4: 231–235, 1995
Dalack GW, Glassman AH, Rivelli S, Covey L, Stetner F: Mood, major depression, and fluoxetine response in cigarette smokers. Am J Psychiatry 152: 398–403, 1995
Glassman AH: Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry 150: 546–553, 1993
Ferry LH, Robbins AS, Scariati PD, Masterson A, Abbey DE, Burchette RJ: Enhancement of smoking cessation using the antidepressant bupropion hydrochloride (abstract). Circulation 86: 671, 1992
Ferry LH, Burchette RJ: Evaluation of bupropion versus placebo for treatment of nicotine dependence, in New Research Program and Abstracts. 147th Annual Meeting of the Am Psychiatric Assoc, Washington, DC. APA, 1994, pp 199–200
Breslau N, Kilbey MM, Andreski P: Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 48: 1069–1074, 1991
Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ et al.: Smoking and major depression. Arch Gen Psychiatry 50: 36–43, 1993
Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ 3rd, van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: Differences between high-and low-anxiety smokers. J Clin Psychopharmacol 15 (3): 182–191, 1995
West R, Hajek P, McNeill A: Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology 104: 91–96, 1991
Robinson MD, Pettice YL, Smith WA et al.: Buspirone effect on tobacco withdrawal symptoms: A randomized placebo-controlled trial. J Am Board of Family Practice 5: 1–9, 1992
Schwartz JL, Dubitsky M: One-year follow-up results of a smoking cessation program. Canadian Jn Public Health 59: 161–165, 1968
Wei H, Young D: Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms. Brit J Addiction 83 (10): 1221–1226, 1988
Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, Cooper TB: Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 54 (6): 670–679, 1993
Klesges RC, Klesges LM, DeBon M, Shelton ML, Isbell TR, Klem ML: Effects of phenylpropanolamine on withdrawal symptoms. Psychopharmacology 119 (1): 85–91, 1995
Jaen CR, Stange KC, Nutting PA: Competing demands of primary care: A model for the delivery of clinical preventive services. J Fam Pract 38: 166–171, 1994
Wells KB, Lewis CE, Leake B, Schleiter MK, Brook RH: The practices of general and subspecialty internists in counseling about smoking and exercise. Am J Public Health 76: 1009–1013, 1986
US Department of Health and Human Services. Healthy People 2000, midcourse review and 1995 revisions. Washington (DC): US Department of Health and Human Services, Public Health Service, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anderson, C.B., Wetter, D.W. Behavioral and pharmacologic approaches to smoking cessation. Cancer Metastasis Rev 16, 393–404 (1997). https://doi.org/10.1023/A:1005816715064
Issue Date:
DOI: https://doi.org/10.1023/A:1005816715064